Cargando…
C-type Lectin Receptors for Tumor Eradication: Future Directions
Dendritic cells are key regulators in directing immune responses and therefore are under extensive research for the induction of anti-tumor responses. DCs express a large array of receptors by which they scan their surroundings for recognition and uptake of pathogens. One of the receptor-families is...
Autores principales: | Streng-Ouwehand, Ingeborg, Unger, Wendy W. J., van Kooyk, Yvette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759192/ https://www.ncbi.nlm.nih.gov/pubmed/24212951 http://dx.doi.org/10.3390/cancers3033169 |
Ejemplares similares
-
Tumor sialylation impedes T cell mediated anti-tumor responses while promoting tumor associated-regulatory T cells
por: Perdicchio, Maurizio, et al.
Publicado: (2016) -
Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression
por: Unger, Wendy WJ, et al.
Publicado: (2014) -
Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccines
por: van Dinther, Dieke, et al.
Publicado: (2017) -
Targeting of the C-Type Lectin Receptor Langerin Using Bifunctional Mannosylated Antigens
por: Li, Rui-Jun Eveline, et al.
Publicado: (2020) -
Glycan modification of antigen alters its intracellular routing in dendritic cells, promoting priming of T cells
por: Streng-Ouwehand, Ingeborg, et al.
Publicado: (2016)